全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... Shintaro Takao , Takeshi Azuma , Masaru Yoshida
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Triple-negative breast cancer (TN) is more aggressive than other subtypes of breast cancer and has a lower survival rate. Furthermore, detailed biological information about the disease is lacking. This study investigated characteristics of metabolic pathways in TN.
作者:... Shin Nishiumi , Masaru Yoshida , Takeshi Azuma
来源:[J].Gut Pathogens(IF 2.738), 2017, Vol.9 (1)Springer
摘要:Helicobacter pylori infection is associated with risk for chronic gastritis (CG), gastric ulcer (GU), duodenal ulcer (DU), and gastric cancer (GC). The H. pylori Cag type IV secretion system (TFSS) translocates the virulence factor cytotoxin-associated gene A protein into host ce...
作者:Masaru Yoshida , Takeshi Azuma ...
来源:[J].BMC Microbiology(IF 3.104), 2011, Vol.11 (1)Springer
摘要:Abstract(#br) Background(#br)The genome of Helicobacter pylori , an oncogenic bacterium in the human stomach, rapidly evolves and shows wide geographical divergence. The high incidence of stomach cancer in East Asia might be related to bacterial genotype. We used newly devel...
作者:... Takeshi Azuma , Hiromi Yoshida , Masaru Yoshida
来源:[J].International Journal of Molecular Sciences(IF 2.464), 2011, Vol.12 (2), pp.1115DOAJ
摘要:Previously, we reported that vitamin K3 (VK3), but not VK1 or VK2 (=MK-4), inhibits the activity of human DNA polymerase γ (pol γ). In this study, we chemically synthesized three intermediate compounds between VK2 and VK3, namely MK-3, MK-2 and MK-1, and investigated the inh...
作者:... Hirotaka Hirano , Masaru Yoshida , Takeshi Azuma
来源:[J].PLoS ONE(IF 3.73), 2017, Vol.8 (3)DOAJ
摘要:BACKGROUND: Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular carcinoma (HCC) that can occasionally lead to the shortening of life expectancy. We aimed to make a new and more accurate prognostic model taking into account the course of di...
作者:... Tadaomi Takenawa , Takeshi Azuma , Masaru Yoshida
来源:[J].PLoS ONE(IF 3.73), 2017, Vol.7 (7)DOAJ
摘要:To improve the quality of life of colorectal cancer patients, it is important to establish new screening methods for early diagnosis of colorectal cancer.We performed serum metabolome analysis using gas-chromatography/mass-spectrometry (GC/MS). First, the accuracy of our GC/MS-ba...
作者:Yoriko Sonoda , Masaru Yoshida , Midori Goto
来源:[J].Acta Crystallographica Section E(IF 0.347), 2009, Vol.65 (2), pp.o294DOAJ
摘要:The title compound, C26H20, lies about an inversion centre. The naphthalene unit and the hexatriene chain are each approximately planar (maximum deviations of 0.0143 and 0.0042 Å, respectively), and are inclined to one another at a dihedral angle of 49.20 (4)°. The dihedral ...
作者:Shin Nishiumi , Yoshihiro Izumi , Masaru Yoshida
来源:[J].Digestive Diseases and Sciences(IF 2.26), 2018, Vol.63 (6), pp.1485-1496Springer
摘要:Abstract(#br) Background(#br)Inflammatory bowel disease (IBD) is an intestinal disorder, involving chronic and relapsing inflammation of the digestive tract. Dysregulation of the immune system based on genetic, environmental, and other factors seems to be involved in the ons...
作者:... Hajime Karasuyama , Masaru Yoshida , Yoshihiro Nishimura
来源:[J].Respiratory Research(IF 3.642), 2011, Vol.12 (1), pp.1-10Springer
摘要:Abstract(#br) Background(#br)There have been few reports on the role of Fc receptors (FcRs) and immunoglobulin G (IgG) in asthma. The purpose of this study is to clarify the role of inhibitory FcRs and antigen presenting cells (APCs) in pathogenesis of asthma and to evaluate...
作者:Masaru Yoshida , Isoko Kuriyama ...
来源:[J].International Journal of Molecular Sciences(IF 2.464), 2011, Vol.12 (2), pp.1115-1132DOAJ
摘要:Previously, we reported that vitamin K3 (VK3), but not VK1 or VK2 (=MK-4), inhibits the activity of human DNA polymerase γ (pol γ). In this study, we chemically synthesized three intermediate compounds between VK2 and VK3, namely MK-3, MK-2 and MK-1, and investigated the inh...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×